-+ 0.00%
-+ 0.00%
-+ 0.00%

Guotai Asset Management says China innovative drug selloff is trading-driven, fundamentals intact

PUBT·08/24/2026 10:18:40
Listen to the news
Guotai Asset Management says China innovative drug selloff is trading-driven, fundamentals intact
  • Guotai Asset Management flagged a fresh selloff in China’s innovative-drug stocks, extending Friday’s sharp pullback.
  • Trading-driven retreat hit vaccine names, AI drug-discovery themes; short-term funds took profits as the broader A-share rebound faded into range trading.
  • STAR Market innovative-drug shares tracked a broader STAR index drop, eroding relative performance versus Hong Kong-listed innovative-drug stocks.
  • The firm saw no fundamental deterioration; it cited a mid-year earnings-driven recovery, easing geopolitical overhangs, resilient CXO demand, steady BD activity.
  • Near-term upside momentum may slow; it pointed to potential buy-the-dip, phased positioning once volatility stabilizes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guotai Asset Management Co. Ltd. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.